<?xml version="1.0" encoding="UTF-8"?>
<list>
  <sentences>
    <s path="[OANC]/data/written_2/technical/biomed/1471-2334-1-17.anc" start="10517" end="10521" sStart="10424" offset="93" sid="r7.1.use.v.0725" wn="1" wnkey="use%2:34:01::" text="The energy change of 0.05 Kcal/mol between two successive structures was used as the termination criterion in both the steps." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2334-1-17.anc" start="9286" end="9297" sStart="null" offset="0" sid="null" wn="2 3" wnkey="null" text="The filtrates were &lt;b&gt;transferred&lt;/b&gt; to a similar device with a M w cut-off of 50,000 and centrifuged under the same conditions." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2334-1-17.anc" start="9286" end="9297" sStart="null" offset="0" sid="null" wn="3" wnkey="transfer%2:38:05::" text="The filtrates were &lt;b&gt;transferred&lt;/b&gt; to a similar device with a M w cut-off of 50,000 and centrifuged under the same conditions." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2334-1-17.anc" start="9101" end="9112" sStart="null" offset="0" sid="null" wn="3" wnkey="transfer%2:38:05::" text="The mixtures were &lt;b&gt;transferred&lt;/b&gt; into a Centricon centrifugal ultrafiltration device with a M w cut-off of 100,000 and centrifuged at 3,500 ? g for 30 min." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2334-1-17.anc" start="9286" end="9297" sStart="null" offset="0" sid="null" wn="4" wnkey="transfer%2:38:00::" text="The filtrates were &lt;b&gt;transferred&lt;/b&gt; to a similar device with a M w cut-off of 50,000 and centrifuged under the same conditions." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2334-1-17.anc" start="13156" end="13163" sStart="null" offset="152" sid="r8.suggest.v.0953" wn="3" wnkey="suggest%2:32:02::" text="These results indicate that treated HIV-1 particles, utilizing either CXCR4 or CCR5 as coreceptors, retain CAP on their surface and suggest that this is responsible for the altered properties and impaired infectivity of the treated viruses." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2334-1-17.anc" start="17784" end="17790" sStart="null" offset="102" sid="r11.strong.j.0880" wn="1" wnkey="strong%3:00:00::" text="1), in agreement with recent observations [ 44 45 ] . Virus inactivation can be attributed to strong binding of CAP to HIV-1, preventing the access to virus particles predominantly of antibodies against the gp120 V3 loop, known to be involved in coreceptor binding and specificity [ 15 46 47 48 49 ] , and to epitopes located adjacent to the V3 loop (Fig." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2334-1-17.anc" start="14534" end="14539" sStart="null" offset="3" sid="r1.order.n.0034" wn="2147483647" wnkey="null" text="In order to determine whether R5 viruses are similarly affected by CAP, the binding of HIV-1 BaL as a representative of this virus group to anti-V3 BaL and CCR5, respectively, before and after CAP treatment was studied." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2334-1-17.anc" start="14534" end="14539" sStart="null" offset="3" sid="r1.order.n.0034" wn="2147483647" wnkey="null" text="In order to determine whether R5 viruses are similarly affected by CAP, the binding of HIV-1 BaL as a representative of this virus group to anti-V3 BaL and CCR5, respectively, before and after CAP treatment was studied." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2334-1-17.anc" start="14534" end="14539" sStart="null" offset="3" sid="r1.order.n.0034" wn="2147483645" wnkey="null" text="In order to determine whether R5 viruses are similarly affected by CAP, the binding of HIV-1 BaL as a representative of this virus group to anti-V3 BaL and CCR5, respectively, before and after CAP treatment was studied." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2334-1-17.anc" start="16011" end="16019" sStart="null" offset="12" sid="r9.appear.v.0471" wn="1" wnkey="appear%2:39:00::" text="The binding appeared augmented by ~ 30% in 1 M NaCl." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2334-1-17.anc" start="8462" end="8467" sStart="null" offset="0" sid="null" wn="1" wnkey="add%2:30:00::" text="1 ?g) was &lt;b&gt;added&lt;/b&gt;." />
  </sentences>
</list>